IL-1β, in turn, upregulates SAA1 expression in ovarian cancer cells, establishing a positive feedback loop that promotes the formation of a tumor-promoting immunosuppressive microenvironment and drives ovarian cancer progression. This evidence concerns the gene IL1B and ovarian carcinoma.